Mark Hinton

Mark Hinton is an entrepreneurial scientist with over 20 years of experience in digital disruption, specializing in helping companies achieve paradigm-shifting change.

He is a client-facing C-level executive with strong math and science skills, capable of delivering complex projects to demanding customers and understanding technology trends.

Mark has hands-on experience in developing advanced technologies to bring financial value to various stakeholders, including executives, operational teams, business development, and investors.

His expertise lies in saving time and money on projects through de-risking mechanisms and automation, and using innovation, automation, and integration processes to improve ROI across diverse companies.

With a track record of delivering multiple programs with multidisciplinary teams, Mark's specialties include the design and delivery of clinical trials, data logistics, and management for clinical trials, as well as cloud-based solutions and statistical analysis plans.

As a physicist with 30 years of experience, he excels in managing complex systems and business processes, particularly in delivering phase I-III clinical trial programs for major pharmaceutical, biotech, and medical device companies.

Mark has extensive experience in integrating protocol compliance data, financial information, and performance metrics through algorithms to enhance analytics reports and alert for anomalies requiring preventive action and human intervention.

He has successfully managed the development of cloud solutions for image management and review in clinical research, conforming to European and FDA standards, and has expertise in clinical trial operational de-risking.

Moreover, Mark has 10+ years of experience in managing quality standards and standard operating procedures in clinical trials for medical device, biotech, and pharmaceutical companies, along with a solid background in delivering regulatory-compliant clinical trials.